Older Diabetes Drugs Linked to Reduced Dementia Risk in Study – Bloomberg Law

By Tim Loh
An older class of diabetes drugs appeared to lower the risk of developing dementia in a study, suggesting the inexpensive medicines could be researched to help combat the growing societal burden of cognitive decline.
People who took an older class of diabetes drugs known as glitazones, or TZDs, had a 22% lower risk of developing dementia in an observational study published in the journal BMJ Open Diabetes Research & Care.
The findings suggest more research could be done on glitazones for dementia, an umbrella term for the impaired ability in some people to remember, think or make decisions. The most …
To read the full article log in.
Learn more about a Bloomberg Law subscription.


Add a Comment

Your email address will not be published. Required fields are marked *